Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
0.5921
-0.0079 (-1.32%)
At close: Apr 1, 2025, 4:00 PM
0.5955
+0.0034 (0.57%)
After-hours: Apr 1, 2025, 4:50 PM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $2.62 million as of April 1, 2025. Its market cap has decreased by -87.69% in one year.
Market Cap
2.62M
Enterprise Value
2.00M
1-Year Change
-87.69%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $2.62M, a decrease of -99.19%. That is a compound annual growth rate of -76.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 2.66M | -71.56% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |